Tryptase-positive mast cells and CD8-positive T cells in human endometrial cancer

Pathology International

Volumn 61, Issue 7, 2011, Pages 442-444

  Ribatti, Domenico ^a   Nico, Beatrice ^a   Finato, Nicoletta ^b   Crivellato, Enrico ^b  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

CD19+ B cells; CD8+ T cells; Endometrial adenocarcinoma; Inflammation; Mast cells; Tumor progression

Indexed keywords

TRYPTASE;

ADENOCARCINOMA; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAST CELL; PATHOGENESIS; PRIORITY JOURNAL;

ADENOCARCINOMA; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MAST CELLS; NEOPLASM INVASIVENESS; NEOPLASM STAGING;

EID: 79959631082     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2011.02680.x     Document Type: Article

References (20)

1. Salvesen HB, Akslen LA. Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas. Int J Cancer 1999; 84: 538-43.
2. Ohno S, Ohno Y, Suzuki N etal. Correlation of histological localizaztion of tumor-associated macrophages with clinicopathological features in endometrial cancer. Anticancer Res 2004; 24: 3335-42.
3. Wallace AE, Sales KJ, Catalano RD etal. Prostaglandin F2α-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinoma. Cancer Res 2009; 69: 5276-87.
4. Yamazawa K, Seki K, Matsui H, Sekiya S. Significance of perivascular lymphocytic infiltrates in endometrial carcinoma. Cancer 2001; 91: 1777-84.
5. + T lymphocytes lineage in human endometrial carcinoma. Int J Gynecol Cancer 2005; 15: 1073-80.
6. Ohno Y, Ohno S, Suzuki N etal. Role of cyclooxygenase-2 in immunomodulation and prognosis of endometrial carcinoma. Int J Cancer 2005; 114: 696-701.
7. Miyatake T, Tringler B, Liu W etal. B7-H4 (DD-=110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration. Gynecol Oncol 2007; 106: 119-27.
8. + lymphocytes correlates with intratumoral angiogenesis and endometrial cancer. Gynecol Oncol 2008; 110: 216-21.
9. Tanaka Y, Kobayashi H, Suzuki M etal. Thymidine phosphorylase expression in tumor-infiltrating macrophages may be correlated with poor prognosis in uterine endometrial cancer. Hum Pathol 2002; 33: 1105-13.
10. Ribatti D, Finato N, Crivellato E etal. Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. Am J Obstet Gynecol 2005; 193: 1961-5.
11. Soeda S, Nakamura N, Ozeki T etal. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma. Gynecol Oncol 2008; 109: 122-8.
12. Rose PG. Endometrial carcinoma. N Engl J Med 1997; 335: 640-49.
13. Silverberg SG, Sasano N, Yagima A. Endometrial carcinoma in Miyagi prefecture, Japan: Histopathological analysis of a cancer registry-based series and comparison with cases in American women. Cancer 1982; 449: 1504-10.
14. + T lymphocytes as a prognostic factor of survival in endometrial carcinoma. Clin Cancer Res 2004; 10: 4450-56.
15. + T cells that mediate distruction of tumor cells and tumor-associated vasculature: A novel mechanism for IL-2. J Immunol 2003; 171: 5051-63.
16. McLachlan JB, Hart JP, Pizzo SV etal. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol 2003; 4: 1199-205.
17. + T cells through production of leukotriene B4. Nat Immunol 2004; 4: 974-81.
18. + T cell effector functions. Immunity 2009; 31: 665-76.
19. Arango HA, Icely S, Roberts WS, Cavanagh D, Becker JL. Aspirin effects on endometrial cancer cell growth. Obstet Gynecol 2001; 97: 423-7.
20. Gao J, Niwa K, Sun W etal. Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells. Cancer Sci 2004; 95: 631-7.